Abstract | BACKGROUND/AIMS: METHODOLOGY: With immunohistochemical staining using specific antibodies, we classified 26 esophageal carcinoma cases and 11 dysplasia cases. RESULTS: All esophageal carcinomas clearly expressed VEGF-C. In esophageal dysplasia, 9 (82%) lcases were positive for VEGF-C, and 2 (18%) were negative. In contrast, none of the normal esophageal mucosa expressed VEGF-C. Seventeen (65%) of 26 cases of esophageal carcinoma were positively stained for VEGF-D and 7 (35%) were negative. VEGF-D was also positive in 2 (18%) cases of esophageal dysplasia, but in no cases of normal tissue. VEGF-C was detected in all carcinomas and dysplastic lesions that expressed VEGF-D. CONCLUSIONS: Active production of VEGF-C and -D was observed not only in esophageal carcinomas but also in some dysplastic lesions. This finding raises the possibility that VEGF-C and -D might play positive roles in the early stage of esophageal carcinogenesis.
|
Authors | Makoto Ishikawa, Joji Kitayama, Shinsuke Kazama, Hirokazu Nagawa |
Journal | Hepato-gastroenterology
(Hepatogastroenterology)
2004 Sep-Oct
Vol. 51
Issue 59
Pg. 1319-22
ISSN: 0172-6390 [Print] Greece |
PMID | 15362742
(Publication Type: Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- VEGFC protein, human
- Vascular Endothelial Growth Factor C
- Vascular Endothelial Growth Factor D
|
Topics |
- Aged
- Biomarkers, Tumor
(analysis)
- Carcinoma, Squamous Cell
(pathology)
- Esophageal Neoplasms
(pathology)
- Esophagus
(pathology)
- Female
- Humans
- Immunoenzyme Techniques
- Lymphatic Metastasis
(pathology)
- Male
- Middle Aged
- Mucous Membrane
(pathology)
- Neoplasm Invasiveness
(pathology)
- Neoplasm Staging
- Precancerous Conditions
(pathology)
- Prognosis
- Vascular Endothelial Growth Factor C
(analysis)
- Vascular Endothelial Growth Factor D
(analysis)
|